At Toxikon, we are dedicated to collaborating with you and your suppliers to ensure that the products you develop are effective and safe. We deliver exceptional expertise and service that you can absolutely rely on -- that is timely, efficient and cost-effective.              FOLLOW US ON 

Our Services

Click on any of these Toxikon preclinical development capabilities for more information.

Analytical and Bioanalytical Chemistry 

Biocompatibility Assessment

Biocompatibility Safety Evaluation Guidelines 

Cell and Molecular Biology 

Disease Models

 Efficacy and Surgical Research Services

Extractables and Leachables

Genetic Toxicology

Microbiology

Ocular Program

Pathology

R&D and Discovery

 

 

 

 

 

 

  

 

 

Cli     



 

 

da 

News & Events   

  • Toxikon to Exhibit, Present Poster at 2012 ARVO Annual Meeting in Fort Lauderdale, Florida »more   

  • Toxikon to Exhibit, Present Poster at 28th Annual Society of Quality Assurance (SQA) Meeting and Quality College »more   

  • Toxikon to Feature its Medical and Biopharmaceutical Product Development Expertise at BIOMEDevice Boston »more   

  • Toxikon to Exhibit, Present Poster at Society of Toxicology’s (SOT) 2012 Annual Meeting & ToxExpo »more   

  • Toxikon’s VP Discusses Analytical Testing in Pharmaceutical Outsourcing Magazine »more  

  • Massachusetts Gov. Deval Patrick Visits Toxikon Corporation »more   

  • WEBINAR: Toxikon's Validation/Quality Systems Engineer Discusses Software Validation Efficiencies  »more 

  • Toxikon’s VP Discusses the Preclinical Market in the July/August Issue of Pharmaceutical Outsourcing  »more 

  • Toxikon Begins Construction on Expanded Efficacy and Surgical Research Services Wing  »more 

  • Toxikon Rebrands to Highlight Extensive Preclinical Development Capabilities  »more

Link to Toxikon Belgium Site
Preclinical CRO | Preclinical Development Services from Concept to
toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology/virology, pharmaceutical, medical device, or biotech company, anticancer or antiviral compound, ocular studies, ophthalmic, disease models, Analytical and Bioanalytical Chemistry, Biocompatibility Assessment, biocompatibility Safety Evaluation Guidelines, Cell and Molecular Biology, Disease Models, Efficacy and Surgical Research Services, Extractables and Leachables, microbiology Ocular Drug Program Pathology R&D and Discovery
Toxikon is a preclinical contract research organization (CRO) dedicated to collaborating with biotech, pharmaceutical and medical device researchers to deliver exceptional drug research and development services from concept to final product.